INVESTIGATION ALERT: The Gross Law Firm Notifies Shareholders of Relmada Therapeutics, Inc. of an Investigation and Potential ...
NEW YORK, May 3, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Relmada Therapeutics, Inc.: Before market opened on October 13, 2022, Relmada announced the results of its RELIANCE III study (REL-1017-303), evaluating …